Mathias Flume
Mathias Flume publishes mostly in Economics and Econometrics, Endocrinology, Diabetes and Metabolism and General Health Professions, on topics such as Pituitary Gland Disorders and Treatments, Pharmaceutical Economics and Policy and Health Systems, Economic Evaluations, Quality of Life.
- World rank
- #1,850,404 of 7,710,434 ranked researchers
- Rank in Germany
- #91,295 of 364,343
- Works
- 27
- Citations
- 286
- Citations per work
- 10.6
What does Mathias Flume research?
Mathias Flume's work is mostly in Medicine (33%), Economics, Econometrics and Finance (14%), Health Professions (9%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else1243.6%
- Health Sciences1141.9%
- Medicine933.2%
- Health Professions28.7%
- Social Sciences414.5%
- 1Economics and Econometrics14% of their works
- 2Endocrinology, Diabetes and Metabolism12% of their works
- 3General Health Professions9% of their works
- 4Pediatrics, Perinatology and Child Health7% of their works
- 5Physiology7% of their works
- 6Oncology7% of their works
Research topics
- Pituitary Gland Disorders and Treatments
- Pharmaceutical Economics and Policy
- Health Systems, Economic Evaluations, Quality of Life
- Biosimilars and Bioanalytical Methods
- Health Policy Implementation Science
- Growth Hormone and Insulin-like Growth Factors
- Pharmaceutical Practices and Patient Outcomes
- Cancer survivorship and care
Which keywords describe Mathias Flume's research?
The keywords of their largest research topics: Growth Hormone, Quality of Life, Cushing's Syndrome, Drug Development Costs, Generic Drugs, Pituitary Adenomas, Cost-effectiveness Analysis and Health Utility Measures.
- Qualitative Research
- Patient-Reported Outcomes
- Inappropriate Medication Use
- Immunogenicity
- Cancer Survivorship
- Health Utility Measures
- Pituitary Adenomas
- Drug Development Costs
- Quality of Life
- Growth Hormone
- Cushing's Syndrome
- Generic Drugs
- Cost-effectiveness Analysis
- Biosimilars
- IGF-1
- Implementation Science
- Insulin-like Growth Factors
- Polypharmacy
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Growth Hormone82 topics
- Quality of Life72 topics
- Cushing's Syndrome51 topic
- Drug Development Costs51 topic
- Generic Drugs51 topic
- Pituitary Adenomas51 topic
- Cost-effectiveness Analysis41 topic
- Health Utility Measures41 topic
- Biosimilars31 topic
- Cancer Survivorship31 topic
- IGF-131 topic
- Immunogenicity31 topic
- Implementation Science31 topic
- Inappropriate Medication Use31 topic
- Insulin-like Growth Factors31 topic
- Patient-Reported Outcomes31 topic
- Polypharmacy31 topic
- Qualitative Research31 topic
Where does Mathias Flume work?
Mathias Flume's main affiliation in the publication record is Klinikum Oldenburg, Germany.
How many publications and citations does Mathias Flume have?
OpenAlex counts 27 works and 286 citations for Mathias Flume, an h-index of 9, ranking #1,850,404 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Mathias Flume. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.